| 1 |
Peck MD. Epidemiology of burns throughout the world. Part I: Distribution and risk factors[J]. Burns, 2011, 37(7):1087-1100.
|
| 2 |
Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management: part 1--evaluating the evidence[J]. Dermatol Surg, 2014, 40(8):817-824.
|
| 3 |
Levine E, Degutis L, Pruzinsky T, et al. Quality of life and facial trauma: psychological and body image effects[J]. Ann Plast Surg, 2005, 54(5):502-510.
|
| 4 |
Gold MH, Mcguire M, Mustoe TA, et al. Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment[J]. Dermatol Surg, 2014, 40(8):825-831.
|
| 5 |
Aarabi S, Bhatt KA, Shi Y, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis[J]. FASEB J, 2007, 21(12):3250-3261.
|
| 6 |
Wilhelmi BJ, Blackwell SJ, Phillips LG. Langer's lines: to use or not to use[J]. Plast Reconstr Surg, 1999, 104(1):208-214.
|
| 7 |
Harris GJ, Sakol PJ, Beatty RL. Relaxed skin tension line incision for dacryocystorhinostomy[J]. Am J Ophthalmol, 1989, 108(6):742-743.
|
| 8 |
Kim JS, Hong JP, Choi JW, et al. The efficacy of a silicone sheet in postoperative scar management[J]. Adv Skin Wound Care, 2016, 29(9):414-420.
|
| 9 |
Block L, Gosain A, King TW. Emerging therapies for scar prevention[J]. Adv Wound Care (New Rochelle), 2015, 4(10):607-614.
|
| 10 |
Kim SM, Choi JS, Lee JH, et al. Prevention of postsurgical scars: comparsion of efficacy and convenience between silicone gel sheet and topical silicone gel[J]. J Korean Med Sci, 2014, 29 Suppl 3:S249-S253.
|
| 11 |
Hayashi T, Furukawa H, Oyama A, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision[J]. Dermatol Surg, 2012, 38(6):893-897.
|
| 12 |
Gassner HG, Brissett AE, Otley CC, et al. Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study[J]. Mayo Clin Proc, 2006, 81(8):1023-1028.
|
| 13 |
Ziade M, Domergue S, Batifol D, et al. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study[J]. J Plast Reconstr Aesthet Surg, 2013, 66(2):209-214.
|
| 14 |
Chang CS, Wallace CG, Hsiao YC, et al. Botulinum toxin to improve results in cleft lip repair[J]. Plast Reconstr Surg, 2014, 134(3):511-516.
|
| 15 |
Lu WS, Zheng XD, Yao XH, et al. Clinical and epidemiological analysis of keloids in Chinese patients[J]. Arch Dermatol Res, 2015, 307(2):109-114.
|
| 16 |
Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options[J]. Clin Cosmet Investig Dermatol, 2013, 6:103-114.
|
| 17 |
Perez OA, Viera MH, Patel JK, et al. A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars[J]. J Drugs Dermatol, 2010, 9(5):514-518.
|
| 18 |
Beuth J, Hunzelmann N, Van Leendert R, et al. Safety and efficacy of local administration of contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany[J]. In Vivo, 2006, 20(2):277-283.
|
| 19 |
Márque García A, Ojeda Vila T, Ferrándiz L, et al. Hypertrophic and keloid scars after the application of 5% imiquimod cream: a report of 2 cases[J]. Actas Dermosifiliogr, 2014, 105(8):795-797.
|
| 20 |
Chuangsuwanich A, Gunjittisomram S. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids[J]. J Med Assoc Thai, 2007, 90(7):1363-1367.
|
| 21 |
Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids[J]. J Am Acad Dermatol, 2002, 47(4 Suppl):S209-S211.
|
| 22 |
Berman B, Harrison-Balestra C, Perez OA, et al. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study[J]. J Drugs Dermatol, 2009, 8(5):455-458.
|
| 23 |
Perez OA, Viera MH, Patel JK, et al. A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars[J]. J Drugs Dermatol, 2010, 9(5):514-518.
|
| 24 |
van der Veer WM, Jacobs XE, Waardenburg IE, et al. Topical calcipotriol for preventive treatment of hypertrophic scars: a randomized, double-blind, placebo-controlled trial[J]. Arch Dermatol, 2009, 145(11):1269-1275.
|
| 25 |
Rabello FB, Souza CD, Farina JJ. Update on hypertrophic scar treatment[J]. Clinics (Sao Paulo), 2014, 69(8):565-573.
|
| 26 |
Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature[J]. Arch Facial Plast Surg, 2006, 8(6):362-368.
|
| 27 |
Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids[J]. Dermatol Surg, 2004, 30(1):54-56, 56-57.
|
| 28 |
Hatamipour E, Mehrabi S, Hatamipour M, et al. Effects of combined intralesional 5-fluorouracil and topical silicone in prevention of keloids: a double blind randomized clinical trial study[J]. Acta Med Iran, 2011, 49(3):127-130.
|
| 29 |
Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study[J]. Int J Dermatol, 2005, 44(9):777-784.
|
| 30 |
Berman B, Duncan MR. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro[J]. J Am Acad Dermatol, 1989, 21(4 Pt 1):694-702.
|
| 31 |
Tredget EE, Shankowsky HA, Pannu R, et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b[J]. Plast Reconstr Surg, 1998, 102(5):1317-1328, discussion 1329-1330.
|
| 32 |
Li-Tsang CW, Feng B, Huang L, et al. A histological study on the effect of pressure therapy on the activities of myofibroblasts and keratinocytes in hypertrophic scar tissues after burn[J]. Burns, 2015, 41(5):1008-1016.
|
| 33 |
Son D, Harijan A. Overview of surgical scar prevention and management[J]. J Korean Med Sci, 2014, 29(6):751-757.
|
| 34 |
Nouri K, Jimenez GP, Harrison-Balestra C, et al. 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day[J]. Dermatol Surg, 2003, 29(1):65-73.
|
| 35 |
Nd: YAG laser treatment for keloids and hypertrophic scars: An Analysis of 102 Cases: Erratum[J]. Plast Reconstr Surg Glob Open, 2015, 3(4):1.
|
| 36 |
Makboul M, Makboul R, Abdelhafez AH, et al. Evaluation of the effect of fractional CO2 laser on histopathological picture and TGF-beta1 expression in hypertrophic scar[J]. J Cosmet Dermatol, 2014, 13(3):169-179.
|
| 37 |
Nast A, Eming S, Fluhr J, et al. German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids)[J]. J Dtsch Dermatol Ges, 2012, 10(10):747-762.
|
| 38 |
Negenborn VL, Groen JW, Smit JM, et al. Autologous fat grafting: a promising technique with various indications. Reply: the use of autologous fat grafting for treatment of scar tissue and scar related conditions: a systematic review[J]. Plast Reconstr Surg, 2016, 138(6):1077e-1078e.
|